Nivolumab is a cancer medicine that is used alone or in combination with other medicines to treat adults with:
advanced skin cancer (melanoma);
advanced non-small cell lung cancer;
pleural mesothelioma (cancer that affects the lining of the lungs and chest wall);
kidney cancer;
classical Hodgkin lymphoma;
cancer of the stomach and esophagus;
squamous cell cancer of the esophagus or head and neck;
bladder cancer;
liver cancer; or
colorectal cancer.
Nivolumab is often given when the cancer has spread to other parts of the body (metastatic), or cannot be surgically removed, or has come back after prior treatment.
Nivolumab is sometimes given only if laboratory testing shows specific genetic markers or DNA mutations associated with your cancer.
